Screening rules
Why it screened this way
✗
No hard-rule violations detected.
NSEPharmaceuticalsIndia
Cipla Limited
Cautious₹1,195
-0.08% today · Day ₹1,166 – ₹1,197 · NSE (public)
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
97/100
Cautious
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
Market Cap₹96,320
Revenue₹27,145
Total Debt₹438
Debt / Mcap0.51%
Non-Halal Income0.97%
SectorPharmaceuticals
Price Chart
Loading chart...
52-Week Range6% from low
52-Week Low₹1,166
52-Week High₹1,673
Prev Close₹1,196
Multi-Methodology Screening
Screened against 3 international Shariah standards
ConsensusCautious0/3 pass
S&P Shariah IndicesCautious
Debt Ratio0.5%/ 33.0%
Non-Halal Income1.0%/ 5.0%
Interest Income1.0%/ 5.0%
Receivables5.7%/ 33.0%
Cash & IB Securities28.4%/ 33.0%
SectorAllowed
AAOIFI StandardsCautious
Debt Ratio1.2%/ 30.0%
Non-Halal Income1.0%/ 5.0%
Interest Income1.0%/ 5.0%
Receivables14.7%/ 49.0%
Cash & IB Securities28.4%/ 30.0%
SectorAllowed
FTSE Yasaar (Maxis)Cautious
Debt Ratio1.2%/ 33.0%
Non-Halal Income1.0%/ 5.0%
Interest Income1.0%/ 5.0%
Receivables14.7%/ 50.0%
Cash & IB Securities28.4%/ 33.0%
SectorAllowed
Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.
Compliance check
Green = safe, amber = close to limit, red = over the limit
Debt level
0.51%Current debt
0.45%Income purity
0.97%Interest earned
0.97%Similar stocks
Other stocks in Pharmaceuticals